# Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy

**Authors:** Blake R. Baer, Meghan V. Matheny, Raidizon H. Mercedes, Jay D. Raman

PMC · DOI: 10.3390/curroncol32030125 · Current Oncology · 2025-02-22

## TL;DR

This study compares long-term kidney outcomes for two UTUC treatments, finding that radical nephroureterectomy preserves kidney function better than local ablation.

## Contribution

The study provides a large-scale comparative analysis of renal outcomes between LA and RNU for UTUC using a 10-year follow-up.

## Key findings

- LA preserved higher eGFR and lower creatinine levels compared to RNU.
- LA had higher rates of ESRD and all-cause mortality than RNU.
- No significant difference in dialysis need was observed between the two treatments.

## Abstract

(1) Background: Upper tract urothelial carcinoma (UTUC) is typically managed through radical nephroureterectomy (RNU) or local ablation (LA). Compared to RNU, LA offers nephron-sparing benefit for select patients but may present increased recurrence risk. This study primarily compares long-term differences between LA and RNU in chronic kidney disease (CKD) progression, estimated glomerular filtration rate (eGFR) decline, all-cause mortality, and need for dialysis. (2) Methods: A retrospective cohort study was conducted using the TriNetX database, examining patients with UTUC treated with RNU (n = 2007) or LA (n = 4172). Propensity score matching balanced both cohorts (n = 1965 per group). Risk ratios and hazard ratios with 95% confidence intervals were calculated over 10 years. (3) Results: At 10 years, LA preserved higher mean eGFR (53.49 vs. 46.72; p < 0.001) and lower mean creatinine (1.56 vs. 1.66; p = 0.017). However, LA held a higher incidence of end-stage renal disease (ESRD) (3.6% vs. 2.2%, p = 0.008) and all-cause mortality (26.7% vs. 23.5%, p = 0.016). There was no significant difference in rates of dialysis (p = 0.79). (4) Conclusions: RNU did not carry an increased risk of ESRD, advanced stages of CKD, need for renal dialysis, or overall mortality compared with LA. LA may delay but not totally prevent renal dysfunction when compared to RNU, and exhibits a more gradual timeline.

## Linked entities

- **Diseases:** Upper tract urothelial carcinoma (MONDO:0020654), chronic kidney disease (MONDO:0005300), end-stage renal disease (MONDO:0004375)

## Full-text entities

- **Diseases:** renal dysfunction (MESH:D007674), ESRD (MESH:D007676), UTUC (MESH:D012141), CKD (MESH:D051436)
- **Chemicals:** creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11940996/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11940996/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC11940996/full.md

---
Source: https://tomesphere.com/paper/PMC11940996